study
Erika Hamilton։ Treatment Outcomes of Tucatinib-Based Maintenance Therapy in HER2-Positive MBC
OncoDaily · 16h ago
Sarah Cannon Research Institute
Medicine & Biotech · covered by 3 outlets this week · tracked since 2026-11-07
Press: 3 independent outlet-days
Background
Sarah Cannon Research Institute (SCRI) is a research organization focusing on therapies for patients which include drugs that are in development. Wikipedia ↗
Written by the Alivewire editors from the coverage below, 20h ago. Not medical advice; how the ratings work.
Coverage
